Certificate of Analysis
HPLC verified · Batch #65A3C8
Tirzepatide
Starting dose 2.5mg/week, titrated up to 15mg/week under physician supervision
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. By activating both incretin pathways simultaneously, tirzepatide delivers superior weight loss outcomes compared to single-receptor agonists. Clinical trials have demonstrated average weight reductions of 15-22% of body weight over 72 weeks. All Biohaus tirzepatide is compounded by FDA-registered pharmacies and prescribed by licensed physicians as part of a supervised medical weight management protocol. Includes metabolic monitoring, nutritional guidance, and regular physician consultations.
Best Stacked With
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. By activating both incretin pathways simultaneously, tirzepatide delivers superior weight loss outcomes compared to single-receptor agonists. Clinical trials have demonstrated average weight reductions of 15-22% of body weight over 72 weeks. All Biohaus tirzepatide is compounded by FDA-registered pharmacies and prescribed by licensed physicians as part of a supervised medical weight management protocol. Includes metabolic monitoring, nutritional guidance, and regular physician consultations.
How It Works
Activates both GIP and GLP-1 receptors, providing a dual mechanism for appetite suppression and metabolic improvement. GIP activation enhances fat oxidation and energy expenditure, while GLP-1 activation reduces appetite and slows gastric emptying.
Primary Applications
Weight management, metabolic optimization, insulin resistance
Important Information
This product requires a valid prescription from a licensed physician. Compounded peptides are prepared by licensed, FDA-registered compounding pharmacies under USP 797/795 standards. Compounded medications are not FDA-approved and have not been evaluated for safety, efficacy, or therapeutic equivalence. Individual results may vary. All peptide protocols require physician evaluation and ongoing medical supervision.
Tirzepatide
$449.00